These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2784162)

  • 1. Neutralizing antibody and clinical status of human immunodeficiency virus (HIV)-infected individuals.
    Alesi DR; Ajello F; Lupo G; Vitale F; Portera M; Spadaro F; Romano N
    J Med Virol; 1989 Jan; 27(1):7-12. PubMed ID: 2784162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of human and simian immunodeficiency virus plaque and neutralization assays.
    McKeating JA; McKnight A; McIntosh K; Clapham PR; Mulder C; Weiss RA
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3327-33. PubMed ID: 2575137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
    Sawyer LA; Katzenstein DA; Hendry RM; Boone EJ; Vujcic LK; Williams CC; Zeger SL; Saah AJ; Rinaldo CR; Phair JP
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):341-56. PubMed ID: 1971182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo.
    Nakashima H; Tochikura T; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
    Virology; 1987 Jul; 159(1):169-73. PubMed ID: 3111083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
    Böttiger B; Ljunggren K; Karlsson A; Krohn K; Fenyö EM; Jondal M; Biberfeld G
    Clin Exp Immunol; 1988 Sep; 73(3):339-42. PubMed ID: 3208445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further isolation of HIV strains in Palermo: some biological properties of the new isolates.
    Lupo G; Spadaro F; Portera M; Torregrossa MV; Russo Alesi D; Vitale F; Romano N
    Microbiologica; 1988 Oct; 11(4):329-37. PubMed ID: 3063924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-neutralizing antibodies to HIV-1ANT70 and HIV-1IIIB in sera of African and Belgian HIV-1-infected individuals.
    Nkengasong JN; Peeters M; Ndumbe P; Janssens W; Willems B; Fransen K; Ngolle M; Piot P; van der Groen G
    AIDS; 1994 Aug; 8(8):1089-96. PubMed ID: 7986404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization profiles of sera from human immunodeficiency virus (HIV)-infected individuals: relationship to HIV viral load and CD4 cell count.
    Nokta M; Turk P; Loesch K; Pollard RB
    Clin Diagn Lab Immunol; 2000 May; 7(3):412-6. PubMed ID: 10799454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease.
    Füst G; Tóth FD; Kiss J; Ujhelyi E; Nagy I; Bánhegyi D
    AIDS; 1994 May; 8(5):603-9. PubMed ID: 7914732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children.
    Broliden K; Sievers E; Tovo PA; Moschese V; Scarlatti G; Broliden PA; Fundaro C; Rossi P
    Clin Exp Immunol; 1993 Jul; 93(1):56-64. PubMed ID: 8324904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers.
    Ljunggren K; Moschese V; Broliden PA; Giaquinto C; Quinti I; Fenyö EM; Wahren B; Rossi P; Jondal M
    J Infect Dis; 1990 Feb; 161(2):198-202. PubMed ID: 2299204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive assay for detection and measurement of neutralising antibody to human immunodeficiency virus.
    Osborne R; Mason H; Browning M; Mitchell R; Jarrett W
    J Virol Methods; 1992 Sep; 39(1-2):15-26. PubMed ID: 1430060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing antibodies and the course of HIV-induced disease.
    Wendler I; Bienzle U; Hunsmann G
    AIDS Res Hum Retroviruses; 1987; 3(2):157-63. PubMed ID: 3650100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus neutralizing antibodies at different stages of the HIV disease: increased levels after azidothymidine treatment.
    Schmidtmayerová H; Lackovicová M; Stanková M; Brůcková M; Surový I; Ujhelyi E; Füst G; Mayer V
    Acta Virol; 1992 Mar; 36(2):157-65. PubMed ID: 1359767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional antibody response to human cytomegalovirus in immunocompetent and HIV-1 infected individuals with antibodies that inhibit virus penetration into cells and intercellular transmission of viral infection.
    Alberola J; Tamarit A; Navarro D
    J Med Microbiol; 1999 Oct; 48(10):947-954. PubMed ID: 10510972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of isolate-specific neutralizing activity is correlated with an increased viral burden in rapidly progressing HIV-1-infected patients.
    Lu W; Shih JW; Tourani JM; Eme D; Alter HJ; Andrieu JM
    AIDS; 1993 Nov; 7 Suppl 2():S91-9. PubMed ID: 7909232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
    Carrow EW; Vujcic LK; Glass WL; Seamon KB; Rastogi SC; Hendry RM; Boulos R; Nzila N; Quinnan GV
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolate-specific neutralizing antibodies in patients with progressive HIV-1-related disease.
    Von Gegerfelt A; Albert J; Morfeldt-Månson L; Broliden K; Fenyö EM
    Virology; 1991 Nov; 185(1):162-8. PubMed ID: 1926772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cells.
    Rey F; Barré-Sinoussi F; Schmidtmayerova H; Chermann JC
    J Virol Methods; 1987 Jun; 16(3):239-49. PubMed ID: 3477567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing antibodies and serum interferon levels in the different stages of HIV infection.
    Szabó B; Tóth FD; Kiss J; Ujhelyi E; Füst G; Horváth A; Hollán SR
    Acta Virol; 1990 Apr; 34(2):164-70. PubMed ID: 1975977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.